ArticleScientific data2026
A multimodal retinal image dataset for diabetic retinopathy detection using foundation models.
Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Automated diabetic retinopathy grading and screening using deep learning.International journal of retina and vitreous · 2026Article
- ORDER-DR: external validation of severity grading and referable-risk stratification from fundus images.Frontiers in endocrinology · 2026Article
- Generative artificial intelligence in lung cancer care: current applications, challenges, and future directions.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic Retinopathy (DR), a leading cause of preventable blindness worldwide, underscores the urgent need for robust AI-driven diagnostic tools. Although various deep learning models for retinal imaging have emerged, their evaluation remains constrained by limited public available datasets that lack both large-scale coverage and fine-grained annotations, compromising reliable assessments of model generalizability. To bridge this gap, we introduce a comprehensive multimodal dataset that includes three key retinal imaging modalities: color fundus photography (CFP), optical coherence tomography (OCT), and ultrawide-field fundus imaging (UWF). Our dataset is unprecedented in scale and modality diversity, provides detailed lesion-level annotations and severity grades for DR and Diabetic Macular Edema (DME). We benchmark a range of fundus foundation models and large vision-language models on this dataset, revealing critical performance gaps and domain-specific challenges. By unifying large-scale multimodal data with precisely annotated clinical labels, our work establishes a foundational benchmark to drive advances in AI reliability and real-world clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.